Home » The third round of nucleic acid testing in Lanzhou, Gansu, 2.6642 million people screened 12 positive people – yqqlm

The third round of nucleic acid testing in Lanzhou, Gansu, 2.6642 million people screened 12 positive people – yqqlm

by admin

The third round of nucleic acid testing in Lanzhou, Gansu Province results in 2,664,200 person-times screening and 12 positive persons

Hangzhou Net Release time: 2022-07-12 11:13

CCTV News Client News At the press conference on the prevention and control of the new crown pneumonia epidemic in Lanzhou (the fifth session) held this morning (July 12), the reporter learned that in order to further tap the potential of nucleic acid detection, the medical and nursing forces inside and outside the city should be coordinated. , to enrich the nucleic acid testing team, and the number of sampling personnel in Lanzhou City, Gansu Province increased to 6,891. Further optimize the process of “collection, delivery, inspection and reporting” to ensure that a round of nucleic acid detection and screening is completed within 24 hours. A total of 2.6642 million people were sampled in the third round of nucleic acid testing and screening, and 12 positive people were screened. Improve the efficiency of single-tube identification, set up 110 emergency sampling teams, quickly track the people who are found to be positive for mixed tubes, and carry out single-person and single-tube nucleic acid testing, epidemiological investigations, and closure and control. As of 10:00 on July 12, a total of 3,794 close contacts and 3,054 close contacts have been tracked, and corresponding control measures have been implemented.

Source: CCTV News Client Author: Reporter Wang Yan Ma Lingfeng Yang Qingbo Wang Peng Ouyang Ren Yuan Zhang Yuanshu Editor: Chen Zhouying

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy